$ALKS: USPTO to review Alkermes Vivitrol patent

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Seeking Alpha (https://seekingalpha.com)

Summary: Alkermes plc (NASDAQ:ALKS) discloses that the USPTO’s Patent Trial and Appeal Board will allow an inter partes review of 13 claims of its U.S. Patent No.

Full article address: https://seekingalpha.com/news/3408334-uspto-review-alkermes-vivitrol-patent

Related News:

$ALKS: Alkermes shares dip despite ‘positive’ trial results from …

$ALKS: EQUITY ALERT: Rosen Law Firm Announces Investigation of …

$ALKS: Just How Bad Is Alkermes’ Depression Drug Setback?

$ALKS: Why Alkermes’ Depression Drug Stumbled, and How Illumina Plans …

$ALKS: Why the FDA Is Dragging Alkermes Down

$ALKS: Alkermes Is Making All The Right Moves In 2018

$ALKS: Alkermes Reports on Outcome of FDA Advisory Committee Meeting …

$ALKS: Alkermes shares halted

$ALKS: Alkermes down 6% premarket ahead of Ad Com for buprenorphine …

$ALKS: Alkermes (ALKS) CEO Richard Pops on Q3 2018 Results – Earnings …

$ALKS: Alkermes PLC (ALKS) Q3 2018 Earnings Conference Call Transcript

Latest News:

$SFIX: Stitch Fix Stumbles Again

$CBSA: CBS Directors Fear Legal Risks from Leaks in Moonves Probe

$ARLO: Bragar Eagel & Squire, PC is Investigating Arlo Technologies, Inc …

$SPPI: Here’s Why Spectrum Pharmaceuticals Rose 21.5% in November

$IIVI: Why Finisar Shares Rose 40% Last Month

$CIVI: Civitas Solutions, Inc. Announces Date of Annual Meeting of …

$HSBA.LN: Huawei CFO Case Hinges on an Offshore Puzzle

$CWH: Why Camping World Holdings Stock Jumped 10% in November

$PNC: 4 Stocks Billionaire Warren Buffett and Insiders Love (and 1 They …

$ZUO $HD $LOW $AMD $AAXN $PFG: AMD, Cisco, Home Depot and Axon: ‘Mad Money’ Lightning Round

$ASNA: Ascena Retail Group Inc (ASNA) CEO David Jaffe on Q1 2019 …